Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring

16/12/2020

Updated Guidelines December 2020 Following the publication of the RCOphth recommendations for monitoring in hydroxychloroquine and chloroquine users in 2018, new published evidence prompted a review of the guideline. Recent data have highlighted that hydroxychloroquine retinopathy is more common than previously reported. The prevalence in long-term users appears to be around 7.5% and depending on

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Monitoring

Tel: 07989 595237